Dapagliflozin (5-10 mg daily) - SGLT2 Inhibitor Therapy: clinical trials recruiting now
Fewer than 3 recruiting trials found.
1
Recruiting trials
5
Conditions studied
0
US states with sites
1
Countries
Phase breakdown
Phase 4 1
Conditions being studied
| Condition | Trials |
|---|---|
| Cardiovascular Diseases | 1 |
| Dapagliflozin | 1 |
| Fontan | 1 |
| Heart Failure | 1 |
| Sodium-GLucose coTransporter-2 Inhibitors | 1 |
Recruiting trials involving Dapagliflozin (5-10 mg daily) - SGLT2 Inhibitor Therapy
Common questions
How many recruiting trials involve Dapagliflozin (5-10 mg daily) - SGLT2 Inhibitor Therapy?
1 recruiting trial across 5 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.